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Summary A series of adult testicular germ cell tumours consisting of eight seminomas, 14 non-seminomas (including two cell lines) and two
combined tumours was analysed by comparative genomic hybridization and, in some cases, by interphase fluorescence in situ hybridization.
The gain of 12p was identified in all cases and additional material from chromosomes 7 and 8 was found in over 70% of cases, in keeping with
previous analyses. Other consistent regions of gain included 1q24-q31 (50%), 2p16-pter (41%), 2q22-q32 (45%) and Xql 1-q21 (50%). The
loss of 1p32-p36 (36%), 9q31-qter (36%), 11q14-qter (50%), 16p (36%) and 18p (45%) and the loss of material from chromosomes 4 and 5
(50% and 36% respectively) were also found in all histological subtypes. The loss of 1p material was confirmed in four cases by interphase
FISH analysis and shown, with one exception, not to involve the loss of the D1Z2 locus at 1p36.3, which is commonly deleted in paediatric
germ cell tumours. An association between gain of 6q21-q24 with cases resistant to chemotherapy (P< 0.01) was observed. In addition, loss
of chromosome 19 and 22 material and gain of 5q14-q23, 6q21-q24 and 13q were found at a significantly lowerfrequency in seminoma than
non-seminoma. These regions may contain genes involved in the divergent development of seminoma and non-seminoma.
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Adult and adolescent testicular germ cell tumours (TGCT) are a
heterogeneous group of neoplasms. There are two main entities
based ondistinctclinical andmorphological features, namely semi-
noma (SE) and non-seminoma (NS). The latter may be composed
of neoplastic embryonic (embryonal carcinoma, immature and
mature teratoma) or extra-embryonic tissue (yolk sac tumour and
choriocarcinoma). In some instances, NS may be found together
with a seminomatous component, in which case they are termed
combined tumours (CT) (Mostofi and Sobin, 1977). Most adult
TGCT areassociated withcarcinomain situ (CIS), fromwhichthey
are thought to be derived (Skakkebaek et al, 1987).
Approximately 80% of TGCT are associated with an isochro-
mosome 12p (Atkin and Baker, 1983; Rodriguez et al, 1992; van
Echten et al, 1995) and in i(12p) negative cases over-representa-
tion of the short arm of chromosome 12 has been demonstrated
(Atkin et al, 1993; Suijkerbuijk et al, 1993; Rodriguez et al, 1993).
Cytogenetic studies have not identified any otherhighly consistent
chromosome rearrangements that are associated with this group of
tumours, although gains and losses of particular chromosomes
have been noted (Rodriguez et al, 1992; Mitelman, 1994; van
Echten et al, 1995). Cytogenetic and other studies have demon-
strated strong genetic similarities between SE and NS. This has led
to the suggestion of a pathogenetic model in which CIS may
progress to SE, associated with chromosome numbers in the
hypertriploid range, which may develop into NS tumours that are
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associated with loss of chromosome material and a hyperdiploid
chromosome complement. NS could also arise directly from CIS
(de Jong et al, 1990; Rodriguez et al, 1992; Damjanov, 1993).
Allele loss studies have identified specific regions ofthe genome
that show loss of heterozygosity (LOH), although the extent and
significance of the loss is not clear (Sandberg et al, 1995). Allele
loss in a proportion ofcases predicted to be greater than by random
loss could indicate significant events in tumorigenesis. LOH may be
associated with deletion of the corresponding genomic region, for
example in a study ofin situ breast carcinoma, 70% ofLOH corre-
sponded to deletion ofthe region (Lu and Shipley, unpublished). In
contrast to molecular analysis ofspecific loci, comparative genomic
hybridization (CGH) (Kallioniemi et al, 1992; du Manoir et al,
1993) screens the whole genome for copy number changes. The
power of CGH for localizing tumour-supressor genes has recently
been demonstrated by its use to localize a tumour-suppressor locus
forPeutz-Jeghers syndrome (Hemminki et al, 1997).
There is cytogenetic evidence for genomic amplification in
more advanced tumours (Samaniego et al, 1990; Suijkerbuijk et al,
1994). Recent studies, including CGH analysis, have identified
amplification of the 12pll.2-pl2.1 region (Suijkerbuijk et al,
1994; Korn et al, 1996; Mostert et al, 1996) and genomic gains
including Ip32-p36, 2p23-p26, 4q12-q13, various regions on 6p,
17q and chromosomes 19 and X (Korn et al, 1996; Mostert et al,
1996; Speicher et al, 1995). CGH has identified consistent regions
of loss including material from chromosomes 4, 5, 6, 13 and 18
(Korn et al, 1996; Mostert et al, 1996). To study the copy number
changes in the genome ofdifferent subtypes ofTGCT further, and
to define the genomic regions that may be significant in tumour
progression, CGH has been used here to screen the genomeofwell
*Present address: Vysis UK, Rosedale House, Rosedale Road, Richmond, Surrey
TW9 2SZ, UK
305306 B Summersgill etal
Table 1 Patient clinical and histological data
Patient Age in years Histologya
at diagnosis
1 46 SE
5 46 SE
8 30 SE
18 32 SE
19 26 SE
33 32 SEb
37 28 SE
44 30 SE
9 30 NS, MTDb
13 32 NS, MTDb
26 30 NS, MTDb
32 36 NS, MTU
35 32 NS, MTI
36 34 NS, MT
39 24 NS, MTI
46 29 NS, MT
47 19 NS, MTDb
48 41 NS, MTI
10 33 CT, (MTI + SE)
34 22 CT, (MTU + SE)
aSE, seminoma; NS, non-seminoma; MT, malignant teratoma; MTD,
malignant teratoma differentiated; MTI, malignant teratoma intermediate;
MTU, malignant teratoma undifferentiated; CT, combined tumour. bTumour
sample received after chemotherapy.
characterized TGCT for specific losses and gains ofgenetic mate-
rial. In particular, we have aimed to define consistent regions of
overlapping copy number change associated with either SE or NS.
In addition, to obtain information about the absolute copy number
ofsome ofthe individual chromosomes andchromosomal regions,
fluorescence in situ hybridization (FISH) with specific markers
has been applied to interphase preparations ofthe tumours.
MATERIALS AND METHODS
Tumour samples and cell lines
Clinical and histological data on the 20 TGCT studied are summa-
rized in Table 1. Tumours with a number less than 30 have been
previously studied for microsatellite instability (Huddart et al,
1995). Samples 33 (SE) and 9, 13, 26 and 47 (NS) were received
after chemotherapy. Normal tissue was trimmed from samples and
the tumour was divided. Part of it was snap-frozen for DNA and
tumour imprint preparation, and the remainder processed for
histopathological examination by standard procedures. In addition,
GCT27 and GCT44, two cell lines derived from NS tumours, were
included in the study (Pera et al, 1987).
CGH and digital image analysis
CGH, capture of digital images and their analysis was carried out
as described previously (Shipley et al, 1996; Weber-Hall et al,
1996a,b). Briefly, 1 gg of normal and tumour DNA (prepared by
standard methods) were directly labelled by nick translation with
eitherfluorescein-12-dUTP orrhodamine-12-dUTP (FluoroGreen,
FluoroRed, Amersham Intemational, Amersham, UK). The reac-
tion was modified to produce DNA fragments 500-2000 bp in size
as assessed on a 1% agarose gel. An aliquot (250-500 ng) of each
labelled DNA plus 15-25 ,ug of CotI DNA (BRL Gibco) was co-
hybridized to normal denatured metaphases for 48 h at 37°C
before washing and mounting in antifade with 0.1,Ig ml-1 DAPI
as a counterstain. Images were captured using a cooled CCD
camera (Photometrics) with SmartCapture software (Digital
Scientific, Cambridge, UK). CGH analysis was carried out using
the same software package and also independently fully analysed
for confirmation of abnormalities using the Quips-XL software
(Vysis, IL, USA). At least five representative images were fully
analysed and the results from these were studied separately and
also combined to produce a mean fluorescence ratio foreach chro-
mosome. A copy number change was indicated when the mean
Table 2 Summary of consistent regions of loss and gain from CGH analysis. The number and percentage of cases of SE, NS and total number of TGCT
showing loss or gain of a specific chromosomal region
Losses SE NS TGCT Gains SE NS TGCT
1p32-p36 2 (25%) 6 (43%) 8 (36%) 1p13-p31 1 (13%) 6 (43%) 7 (32%)
4p 4 (50%) 4 (29%) 8 (36%) 1q24-q31 5 (63%) 6 (43%) 11 (50%)
4q24-qter 6 (75%) 5 (36%) 11 (50%) 2p16-pter 2 (25%) 7 (50%) 9 (41%)
5 4 (50%) 4 (29%) 8 (36%) 2q22-q32 3 (38%) 7 (50%) 10 (45%)
9q31l-qter 1 (13%) 7 (50%) 8 (36%) 5q14-q23** 0 (0%) 6 (43%) 6 (27%)
lop 1 (13%) 5 (36%) 6 (27%) 6q21-q24** 0 (0%) 6 (43%) 6 (27%)
11q14-qter 6(75%) 5(36%) 11 (50%) 7 8(100%) 9(64%) 17(77%)
13q** 4 (50%) 2 (14%) 6 (27%) 8 5 (63%) 11 (79%) 16 (73%)
15q 0 (0%) 4 (29%) 4 (18%) 12p 8 (100%) 14 (100%) 22 (100%)
16p 4 (50%) 4 (29%) 8 (36%) 13q** 0 (0%) 5 (36%) 5 (23%)
17p 2 (25%) 3 (21%) 5 (23%) 21 7 (88%) 8 (57%) 15 (68%)
18p 5 (63%) 5 (36%) 10 (45%) 22* 5 (63%) 2 (14%) 7 (32%)
18q 5(63%) 4(29%) 9(41%) Xq1-q21 3(38%) 8(57%) 11 (50%)
19* 0 (0%) 10 (71%) 10 (45%)
22* 0 (0%) 9 (64%) 9 (41%)
Significant difference between seminoma and non-seminoma: *P< 0.01, **P < 0.05 using Fisher's exact test.
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Figure 1 Mean CGH ratio profiles (with 95% confidence intervals) from the selected cases indicated. The tumour and normal DNA were labelled with red and
green fluorescence respectively. The mean red-green fluorescence intensities were plotted along the length of the chromosome. The vertical midline indicates a
fluorescence ratio of 1 and the parallel lines either side of this show a ratio of 0.2 greater and smaller than this. A copy number change is indicated where the
profile lies on or outside these limits, shown by the bar to the right (gain) or left (loss) of the chromosome. The heterochromatic regions give unreliable ratios
fluorescence ratio lay outside the normal range which was
determined in control experiments using differentially labelled
normal DNA.
Interphase FISH analysis
Interphase FISH analysis was carried out to determine the copy
number of specific chromosomes and chromosomal regions in
tumour nuclei. The interphase preparation and hybridization was
carried out as previously described (McManus et al, 1995) on
cases 1, 37, 39 and 44, using probes specific to the centromeres of
chromosomes X, 4, 7, 10 and 12. A probe for the pericentromeric
region of chromosome 1 and differentially labelled markers local-
izing to different regions of lp were co-hybridized to cases 33, 36,
39, 44 and 47. These markers included two PAC clones, dj 1 7i7
and djl63m9, localized to the lp32 and lp35 regions, respectively,
and also the marker pl-79 for the subtelomeric locus D1Z2 at
lp36.3. A minimum of 100 tumour nuclei were analysed in each
case. The proportion of normal cell contamination, based on
cellular morphology and abnormalities in the copy numbers of
markers, was also determined for cases 33, 36, 39, 44 and 47.
RESULTS
CGH analysis
This study reports the CGH results from 20 TGCTs, detailed in
Table 1, and also two cell lines. In control CGH experiments using
differentially labelled normal DNA, the mean fluorescence ratios
did not exceed 1.0 ± 0.1 (Figure 1). A copy number change
was therefore determined when the mean fluorescence ratio was
1.0 ± 0.2. The more distal region of lp and chromosome 19, which
can sometimes be difficult to analyse by CGH, produced reliable
results in control experiments with normal DNA and consistent
results when the tumour DNA was labelled with either red or green
fluorochromes.
Examples of mean fluorescence profiles of selected cases with
abnormal and normal copy numbers ofchromosomes are shown in
British Journal ofCancer(1998) 77(2), 305-313
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Figure 2 Summary of the gains and losses of genetic material in the (A) seminoma and (B) non-seminoma samples analysed by CGH. Vertical lines on the
right side of a chromosome represent gains of genetic material and vertical lines on the left side correspond to losses. Thick lines are indicative of a higher copy
number change. Case numbers are provided on the top of each line. *Cases of residual tumours after chemotherapy.
Figure 1. For most chromosomes with an abnormal copy number,
the mean ratio did not extend outside the range 1.2-1.4. A ratio of
greater than 1.5 was considered to indicate a higher copy number
change. The results from all the cases studied are summarized in
Figure 2. The location and frequency of overlapping consensus
regions of copy number change are summarized in Table 2. The
copy number changes and their frequency were generally similar
in SE, NS and the cell lines. Most frequent was the gain of 12p
material in all samples and gain ofchromosome 7 and 8 material in
over 70% of cases. The results indicated that some regions were
involved to different extents in SE and NS. Loss of 15q, and chro-
mosome 19 was not found in SE but was found in 29% and 64%,
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Table 3 Interphase FISH analysis of selected patients.
Case Copy number of centromere and % of nuclei in which this
number was observed
X 4 7 10 12
1 (SE) 1 72% 0-2 12% 1 9% 0-1 18% 1-2 16%
2 28% 3 52% 2 18% 2 78% 3 40%
4 30% 3 55% 3 4% 4 28%
5-6 6% 4 18% 5-6 16%
37 (SE) 1 50% 0 100% 3 58% 6 50%
2 17% 4 28% 7 50%
3 33% 8 14%
44 (SE) 1 5% 1-2 4% 3 33% 1 2% 3 16%
2 90% 3 38% 4 20% 2 30% 4 21%
3 5% 4 32% 5 20% 3 64% 5 21%
5-6 26% 6-8 27% 4 4% 6-8 42%
39 (NS) 1 9% 3 13% 2 10% 2 41% 2-3 17%
2 34% 4 50% 3 10% 3 47% 4 16%
3 16% 5 6% 4 25% 4 12% 5-6 33%
4 25% 6 18% 5 25% 10-12 24%
5 16% 8 13% 6-7 30%
Normal 1 2% 1 2% 1 2% 1 2% 1 2%
2 98% 2 98% 2 98% 2 98% 2 98%
respectively, of NS. For chromosome 19 this represents a signifi-
cant difference using Fisher's exact probability test (P = 0.0015).
Similarly, gain of 5ql4-q23 and 6q21-q24 was found in 43% of
NS but not in any SE (P = 0.04). 13q was lost in 50% of SE but
gained in 36% NS and loss of chromosome 22 was apparent in
NS whereas gain ofthis chromosome was found in SE (P = 0.045,
n = 11 andP = 0.0048, n = 16respectively). The samples that were
received after chemotherapy had changes similar to the other cases
with the exception that gain of6q21-q24 was significantly associ-
ated with the resistant tumours compared with the remainder (four
out offive samples compared with two out of 17, P = 0.00934).
Interphase FISH analysis
Interphase FISH was carried out on selected cases with specific
centromere probes (Table 3). The centromere copy numbers in
tumourcells showed heterogeneity and there was a variable amount
ofnormal cell contamination (Table 4). The size ofthe centromere
signals for chromosome 12 was variable and their copy numbers
generally high. This was attributed to the presence of the i(12p)
chromosome, although it is not possible to predict in individual
cases whether the rearrangement producing this chromosome
results in a larger or smaller centromeric signal than that found in
the normal chromosome 12 (Mukherjee et al, 1991). The results
from the analysis of the copy number of the PACs from the lp32
and lp35 region in relation to the pericentromeric probe for chro-
mosome 1 for cases 33, 44, 36 and 39 showed loss of the region,
consistent with the CGH analysis. However, similar analysis forthe
D1Z2 locus demonstrated, with one exception (case 36), that the
D1Z2 locus was not lost (Table 4 and Figure 3). The interphase
results for case 47 indicated loss of the pericentromeric marker in
addition to the lp markers, which was consistent with CGH
analysis that showed loss ofthe whole chromosome.
DISCUSSION
Adult germ cell tumours are a heterogeneous group of neoplasms
both clinically and histologically and can display variable degrees
of cellular differentiation. This study has identified regions of the
genome frequently gained and lost in a total of22 samples derived
from different subtypes ofTGCT, including five cases resistant to
Table 4 Interphase FISH analysis of selected cases showing loss of 1p
Case number Normal Copy number frequency of markers for Region Loss of Loss of
cells (%) pericentromeric region (1 cent), D1Z2 of loss subtelomeric 1p32-35
locus, 1p35 and 1p32 regions in tumour indicated region region
nuclei by CGH
1cent 1p36.3 PAC PAC
1p35 1p32
33 (SE) 50 5 5% 510% 4100% 4 100% 1p12-36.1 No Yes
6 90% 6 90%
75%
44 (SE) 45 3100% 2 30% 0 5% 0 5% 1p32-pter No Yes
3 70% 1 20% 120%
2 70% 2 70%
35% 35%
36 (NS) 60 410% 2 15% 2 5% 210% 1p32-pter Yes Yes
5 90% 3 80% 3 5% 4 90%
45% 485%
55%
39 (NS) 20 2 55% 2 40% 020% 1 60% 1p32-pter No Yes
410% 5-6 60% 1 50% 2 20%
510% 2-3 20% 320%
6 25% 4-5 10%
47 (NS) 30 1 80% 1 76% 1 65% 1 70% chr 1 Yes Yes
2 5% 2 6% 2 25% 2 10%
310% 318% 3-410% 310%
5 5% 410%
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Figure 3 Example of interphase FISH analysis of 1p markers. The marker for the pericentromeric region of chromosome 1 (green) was co-hybridized to nuclei
from case 33 in separate experiments with differentially labelled markers (red) for (A) a PAC clone localizing to 1p35, (B) a PAC clone localizing to 1p32, and (C)
the D1Z2 locus at the subtelomeric region of 1p. A and B show six signals corresponding to the pericentromeric region of chromosome 1 (green) and only four
signals for each of the PAC clones (red). This loss, encompassing the 1p32-35 region, is consistent with the CGH analysis. However, equal numbers of signal
for the pericentromeric and D1Z2 markers were found (C), which is interpreted as retention of this locus
chemotherapy. This has been achieved using the approach ofCGH,
and also, in some cases, interphase FISH analysis.
The CGH approach is limited in the copy number changes it can
detect. Theoretically, a single copy number change in a triploid
genome would alter the ratio by 0.33 in the absence of contamina-
tion by normal cells or a heterogeneous cell population.
Approximately more than one-third contamination would mean
that single copy changes would not be detected using the criteria
set out in the Materials and methods. The percentage contamina-
tion in the cases examined ranged from 20% to 60% and hetero-
geneity was found in the copy number of markers in nuclei as
noted in other interphase studies (Looijenga et al, 1993; Speicher et
al, 1995). The results are therefore considered to underestimate the
frequency oflow-level copy number changes. A similar conclusion
was previously reported (Mostert et al, 1996). CGH analysis is also
limited in resolution to detecting deletions greater than ten
megabases in size. However, despite these limitations, CGH has
been used here to identify areas of copy number change that are
consistent with previous cytogenetic studies and LOH analysis.
Novel regions of consistent gain and loss have also been deter-
mined that may indicate the location of oncogenes and tumour-
suppressor genes involved in the development ofthese tumours.
Strikingly similar copy number changes were found in both the
SE and NS analysed, in keeping with their suggested common
developmental pathway (de Jong et al, 1990; Rodriguez et al,
1992; Damjanov, 1993; Sandberg et al, 1995). Regions, common
to NS and SE, included loss of 'p32-36 (36%), 9q31-qter (36%),
I lql4-qter (50%), 16 p(36%), 17p (23%) and l9p (45%) and loss
of material from chromosomes 4 (50%) and 5 (36%). Gain of the
regions lq24-q31 (50%), 2pl6-pter (41%), 2q22-q32 (45%), 12p
(100%), Xqll-q21 (50%) and chromosomes 7 and 8 (> 70%)
were also found in all histological subtypes.
The most consistent CGH finding was additional 12p material,
which is in keeping with the i(l2p) chromosome found in 80% of
TGCT and the over-representation of 12p material determined in
FISH studies of i(12p) negative cases (Atkin et al, 1993;
Rodriguez et al, 1993; Suijkerbuijk et al, 1993). Cases with addi-
tional copies of the 12pl1.2-12.1 region have been previously
reported, suggesting that a subgroup of TGCT amplifies this
region (Suijkerbuijk et al, 1994; Korn et al, 1996; Mostert et al,
1996). None of the current series showed over-representation of
this region, although we have recently identified a single case from
a paraffin-embedded sample (B Summersgill, data not shown).
Loss of material from lp was found in 36% ofthe cases studied,
with the consistent region of loss determined as lp32-p36.
Interphase FISH using markers from the lp32 and lp35 region
substantiated the CGH analysis. This loss is consistent with cyto-
genetic reports of deletions in the short arm of chromosome 1
(Rodriguez et al, 1992; Mitelman, 1994; van Echten et al, 1995).
Variable amounts ofloss have been revealed by allelotype analysis
of various loci on lp (Wang et al, 1980; Parrington et al, 1987;
Mathew et al, 1994), including up to 45% LOH in one of these
studies (Mathew et al, 1994). These results contrast with a recent
CGH study ofTGCT, which determined gain rather than loss of Ip
material (Korn et al, 1996).
Loss ofmaterial at the subtelomeric region of lp has been found
as a common region of loss in various categories of germ cell
tumours from young children. Cytogenetic analysis of GCT of the
endodermal sinus type suggested a common area of deletion at
lp36 (Perlman et al, 1996). Interphase analysis using the marker for
the PITSLRE locus at lp36, a candidate tumour-suppressor gene
for involvement in neuroblastoma, demonstrated loss of this locus
in eight out of ten paediatric cases. Similarly, Stock et al (1994)
demonstrated loss ofthe DIZ2 locus in four GCTs ofchildren (two
testicular embryonal carcinomas and two sacral yolk sac tumours).
The present study shows that the D1Z2 locus is not commonly lost
in the adult TGCT and larger regions of lp are lost than in the
paediatric cases. This difference may be significant in the different
clinical and biological characteristics ofadult and childhood GCTs.
Loss of material from chromosome 18 was found in over half of
the cases studied. A high frequency of LOH has been reported for
the DCC gene at 18q21.3, leading to the suggestion that loss of
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function ofthis gene may be important in germ cell tumour patho-
genesis (Murty et al, 1994). However, one cannot exclude the
possibility that other genes might be significant. Loss ofchromo-
some 5 was found in approximately one-third of cases and corre-
lates with LOH reported at 5pl5.1-pl5.2, Sqll and 5q34-q35
(Murty et al, 1996). Loss of chromosome 4 material, particularly
4p and 4q24-qter, was found in over halfthe cases and may be of
significance. Similarly, specific loss ofthe 11q14-qter region was
frequently found.
A number of common regions of gain were found as summa-
rized in Table 2. These included gain of the lp24-q31 region and
the 2p13-pterregion, including three cases withgainof2p24-p25.
Gain and amplification ofthis latter region has been noted and the
NMYC gene suggested as a candidate (Kom et al, 1996). Gain of
chromosome X, with a common overlapping region ofXqll-q21,
was found. Klinefelter's syndrome (47, XXY) patients show an
increased incidence ofGCT and the cytogenetics ofextra gonadal
GCT and TGCT show an excess number of chromosome X
(Mitelman, 1994). Taken together with our results, this suggests a
role for the X chromosome, and possibly XqlI-q21 in particular,
in the development ofadult GCT.
In addition, some overlapping regions of copy number change
were less frequent or not found in the seminoma compared with
the non-seminoma. These included loss of 15q and chromosome
19 material and gain of5ql4-q23 and 6q21-q24. Loss of 13q was
associated with SE whereas gain was noted in the NS and
conversely for chromosome 22, loss was found in NS compared
with gain in SE (Table 2). These results suggest regions that may
contain genes involved in the divergent development of SE and
NS. The reduced levels of expression of the RBI gene at 13q14
noted particularly in SE may reflect the chromosome dosage
differences observed here (Strohmeyer et al, 1991). The difference
in copy number of chromosome 15 and 22 material between SE
and NS is consistent with previous cytogenetic and interphase
FISH studies (Castedo et al, 1989a,b; Looijenga et al, 1993).
One SE and four NS were received after chemotherapy. The
number and sites ofcopy numberchange in these did not appear to
be significantly different from the other samples with the excep-
tion ofgain of6q21-q24, which warrants further investigation.
Determining significant rearrangements in the genome of
TGCT amidst the considerable genomic instability is a difficult
task. In contrast to molecular analysis of specific regions of the
genome, the present study provides a global view of the copy
number changes, and their frequency, which complements
previous cytogenetic studies and indicates genomic regions for
further study.
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